bf/NASDAQ:ANIP_icon.jpeg

COM:ANIPHARMACEUTICALS

ANI Pharmaceuticals

  • Stock

Last Close

55.86

22/11 21:00

Market Cap

1.19B

Beta: -

Volume Today

127.69K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
1.76M
-
5.52M
213.70%
10.45M
89.43%
19.79M
89.28%
31.95M
61.51%
39.12M
22.41%
44.33M
13.34%
54.48M
22.89%
71.25M
30.77%
93.52M
31.27%
108.28M
15.77%
average payables
1.28M
-
2.04M
59.64%
2.36M
15.60%
2.73M
15.57%
3.51M
28.67%
6.26M
78.29%
11.74M
87.71%
12.93M
10.12%
17.11M
32.32%
26.14M
52.72%
32.99M
26.24%
average receivables
6.26M
-
14.90M
138.23%
19.61M
31.60%
33.91M
72.90%
52.34M
54.34%
61.81M
18.10%
68.49M
10.79%
83.96M
22.60%
112.16M
33.59%
146.98M
31.05%
163.76M
11.41%
book value per share
8.08
-
12.78
58.17%
14.08
10.20%
14.82
5.28%
15.13
2.10%
16.89
11.62%
17.97
6.38%
16.36
8.98%
28.48
74.11%
20.82
26.90%
23.79
14.24%
capex per share
-0.04
-
-3.27
8,576.17%
-2.87
12.04%
-13.02
353.09%
-9.35
28.19%
-0.93
90.01%
-2.33
148.97%
-5.71
145.45%
-1.88
67.14%
-1.01
46.07%
capex to depreciation
-0.17
-
-9.22
5,258.05%
-4.74
48.62%
-6.67
40.85%
-3.87
42.04%
-0.32
91.64%
-0.62
90.95%
-1.53
147.86%
-0.50
67.32%
-0.28
44.86%
capex to operating cash flow
0.03
-
-1.62
4,759.24%
-1.89
16.66%
-5.43
186.61%
-2.74
49.51%
-0.16
94.06%
-0.60
271.10%
-4.48
641.24%
-7.12
59.00%
0.53
107.41%
capex to revenue
-0.01
-
-0.64
9,961.04%
-0.43
32.96%
-1.16
170.63%
-0.61
47.31%
-0.05
91.14%
-0.13
146.39%
-0.33
145.71%
-0.11
66.63%
-0.05
52.44%
cash per share
2.19
-
15.45
605.50%
13.60
11.94%
2.39
82.43%
2.70
12.80%
3.68
36.56%
5.26
42.92%
0.66
87.51%
7.96
1,111.44%
2.97
62.75%
12.15
309.75%
days of inventory on hand
128.74
-
239.18
85.78%
384.99
60.96%
195.92
49.11%
174.24
11.07%
202.45
16.19%
278.36
37.50%
254.63
8.52%
296.37
16.39%
277.08
6.51%
days payables outstanding
52.29
-
84.43
61.46%
59.41
29.63%
25.36
57.32%
16.76
33.89%
44.41
164.87%
84.42
90.10%
47.16
44.13%
83.32
76.68%
77.07
7.50%
days sales outstanding
151.83
-
112.80
25.70%
104.89
7.01%
130.24
24.17%
121.34
6.83%
117.41
3.24%
127.46
8.56%
167.72
31.58%
217.05
29.41%
190.86
12.07%
121.52
36.33%
debt to assets
0.03
-
0.42
1,308.65%
0.40
5.27%
0.37
6.02%
0.49
30.85%
0.43
13.07%
0.41
4.32%
0.40
0.99%
0.37
7.50%
0.38
1.21%
0.32
16.21%
debt to equity
0.03
-
0.79
2,346.19%
0.71
10.52%
0.71
0.36%
1.15
62.15%
0.93
19.54%
0.87
5.91%
0.95
8.70%
0.80
15.57%
0.85
5.65%
0.66
22.00%
dividend yield
0.00
-
0.00
658.88%
0.00
34.80%
earnings yield
0.00
-
0.05
1,476.25%
0.03
35.69%
0.01
81.08%
-0.00
125.50%
0.03
2,138.48%
0.01
71.69%
-0.06
877.67%
-0.07
13.10%
-0.07
0.25%
0.02
125.57%
enterprise value
90.72M
-
558.62M
515.75%
471.81M
15.54%
787.07M
66.82%
914.57M
16.20%
665.71M
27.21%
853.65M
28.23%
525.26M
38.47%
767.49M
46.12%
892.43M
16.28%
1.07B
19.65%
enterprise value over ebitda
53.27
-
23.23
56.39%
11.90
48.77%
16.05
34.87%
15.98
0.42%
9.71
39.25%
14.04
44.56%
18.38
30.95%
52.07
183.25%
27.97
46.28%
6.12
78.12%
ev to operating cash flow
-16.54
-
25.35
253.26%
27.33
7.79%
28.65
4.83%
23.20
19.02%
9.92
57.22%
18.71
88.49%
34.40
83.91%
231.03
571.52%
-28.60
112.38%
8.98
131.38%
ev to sales
3.02
-
9.98
230.95%
6.18
38.06%
6.12
1.01%
5.17
15.49%
3.30
36.14%
4.13
25.15%
2.52
39.04%
3.55
40.94%
2.82
20.57%
2.19
22.24%
free cash flow per share
-1.12
-
-1.25
12.06%
-1.36
8.14%
-10.62
683.39%
-5.94
44.10%
4.81
180.99%
1.53
68.25%
-4.43
390.40%
-1.61
63.63%
-2.93
81.72%
6.54
323.08%
free cash flow yield
-0.06
-
-0.02
60.10%
-0.03
35.13%
-0.18
483.15%
-0.09
47.42%
0.11
215.94%
0.02
76.82%
-0.15
716.69%
-0.04
77.08%
-0.07
108.15%
0.12
262.76%
graham net net
3.69
-
5.65
53.20%
4.63
18.09%
-6.84
247.83%
-12.41
81.29%
-10.40
16.18%
-8.74
15.97%
-12.99
48.60%
-13.92
7.17%
-12.09
13.15%
-2.67
77.93%
graham number
3.28
-
27.48
736.74%
20.70
24.69%
10.71
48.27%
5.63
47.39%
22.46
298.68%
14.43
35.77%
26.34
82.57%
46.56
76.77%
37.15
20.21%
23.50
36.73%
income quality
-18.22
-
0.77
104.21%
1.12
46.50%
6.98
521.91%
-36.63
624.61%
4.33
111.82%
7.49
72.97%
-0.68
109.04%
-0.08
88.48%
0.65
935.48%
6.33
872.36%
intangibles to total assets
0.28
-
0.17
39.51%
0.24
43.67%
0.55
130.01%
0.56
2.15%
0.48
15.22%
0.40
15.48%
0.42
3.42%
0.42
0.20%
0.37
11.77%
0.26
28.76%
interest coverage
1.92
-
25.42
1,221.98%
2.97
88.31%
1.77
40.33%
2.35
32.79%
2.40
1.79%
1.26
47.37%
-1.70
234.77%
-2.73
60.46%
-0.89
67.24%
-1.74
95.14%
interest debt per share
0.35
-
10.19
2,781.68%
10.94
7.41%
11.53
5.36%
18.49
60.38%
16.94
8.42%
16.78
0.92%
16.31
2.81%
23.76
45.68%
19.35
18.58%
14.22
26.49%
inventory turnover
2.84
-
1.53
46.17%
0.95
37.87%
1.86
96.51%
2.09
12.44%
1.80
13.93%
1.31
27.27%
1.43
9.32%
1.23
14.08%
1.32
6.96%
invested capital
0.03
-
0.79
2,346.19%
0.71
10.52%
0.71
0.36%
1.15
62.15%
0.93
19.54%
0.87
5.91%
0.95
8.70%
0.80
15.57%
0.85
5.65%
0.66
22.00%
market cap
101.83M
-
616.96M
505.90%
513.07M
16.84%
693.80M
35.22%
744.20M
7.27%
525.70M
29.36%
730.23M
38.91%
347.43M
52.42%
580.42M
67.06%
654.14M
12.70%
1.00B
53.36%
net current asset value
24.18M
-
79.55M
229.03%
67.40M
15.28%
-50.21M
174.49%
-105.78M
110.67%
-80.46M
23.93%
-56.30M
30.03%
-95.17M
69.03%
-91.08M
4.29%
-77.29M
15.15%
72.99M
194.45%
net debt to ebitda
-6.52
-
-2.43
62.79%
-1.04
57.11%
1.90
282.78%
2.98
56.52%
2.04
31.41%
2.03
0.63%
6.22
206.63%
12.69
103.94%
7.47
41.16%
0.37
95.05%
net income per share
0.06
-
2.63
4,326.52%
1.35
48.53%
0.34
74.58%
-0.09
127.11%
1.33
1,523.93%
0.51
61.21%
-1.88
466.20%
-3.38
79.46%
-2.95
12.91%
1.03
135.04%
operating cash flow per share
-1.08
-
2.01
286.21%
1.52
24.60%
2.40
58.09%
3.41
42.22%
5.74
68.26%
3.85
32.91%
1.28
66.89%
0.26
79.33%
-1.92
827.63%
6.54
440.72%
payables turnover
6.98
-
4.32
38.06%
6.14
42.11%
14.39
134.30%
21.77
51.26%
8.22
62.25%
4.32
47.40%
7.74
79.00%
4.38
43.40%
4.74
8.11%
receivables turnover
2.40
-
3.24
34.60%
3.48
7.54%
2.80
19.47%
3.01
7.34%
3.11
3.34%
2.86
7.89%
2.18
24.00%
1.68
22.73%
1.91
13.72%
3.00
57.06%
research and ddevelopement to revenue
0.06
-
0.05
15.93%
0.04
21.30%
0.02
40.00%
0.05
127.01%
0.08
48.84%
0.10
25.61%
0.08
19.96%
0.05
31.47%
0.07
34.10%
0.07
0.16%
return on tangible assets
0.01
-
0.13
1,301.39%
0.07
45.83%
0.03
61.76%
-0.01
122.01%
0.07
1,253.08%
0.02
67.50%
-0.08
475.12%
-0.09
13.09%
-0.10
5.25%
0.03
128.22%
revenue per share
5.93
-
5.12
13.76%
6.71
31.22%
11.24
67.42%
15.31
36.28%
17.26
12.72%
17.44
1.05%
17.43
0.10%
17.16
1.53%
19.46
13.40%
26.76
37.51%
roe
0.01
-
0.21
2,698.64%
0.10
53.30%
0.02
75.86%
-0.01
126.55%
0.08
1,375.67%
0.03
63.54%
-0.12
502.32%
-0.12
3.07%
-0.14
19.13%
0.04
130.67%
roic
0.02
-
0.12
563.22%
0.08
28.61%
0.03
62.93%
-0.00
115.80%
0.07
1,549.99%
0.08
10.22%
-0.04
146.19%
-0.04
4.54%
-0.03
19.86%
0.06
301.60%
sales general and administrative to revenue
0.54
-
0.32
41.18%
0.28
13.50%
0.22
21.95%
0.18
17.46%
0.22
22.41%
shareholders equity per share
8.08
-
12.78
58.17%
14.08
10.20%
14.82
5.28%
15.13
2.10%
16.89
11.62%
17.97
6.38%
16.36
8.98%
28.48
74.11%
20.82
26.90%
23.79
14.24%
stock based compensation to revenue
0.15
-
0.06
58.69%
0.05
17.39%
0.05
6.64%
0.03
26.99%
0.03
2.30%
0.04
32.63%
0.06
39.05%
0.05
21.79%
0.05
4.92%
0.04
8.06%
tangible asset value
28.71M
-
95.88M
233.90%
91.85M
4.21%
-7.98M
108.69%
-56.87M
612.50%
-7.92M
86.07%
28.82M
463.88%
3.61M
87.48%
36.73M
917.73%
58.68M
59.77%
220.37M
275.52%
tangible book value per share
5.66
-
8.76
54.76%
8.08
7.82%
-0.70
108.63%
-4.93
606.21%
-0.68
86.23%
2.43
458.84%
0.30
87.61%
2.92
866.67%
3.61
23.77%
12.11
235.60%
working capital
24.18M
-
190.25M
686.85%
180.83M
4.95%
71.06M
60.70%
92.38M
30.00%
-12.67M
113.72%
126.02M
1,094.47%
91.76M
27.19%
234.24M
155.28%
244.82M
4.52%
374.34M
52.90%

All numbers in (except ratios and percentages)